{"id":481708,"title":"Notice of Consultation on the Prescription Drug List (PDL): Brimonidine  - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T17:20:21.096000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/consultation-brimonidine.html?wbdisable=true","snippet":"Notice of Consultation on the Prescription Drug List (PDL): Brimonidine Date: August 27, 2021 Our file number: 21-115489-476 This Notice of Consultation provides an opportunity to comment on the proposal to revise the listing for brimonidine or its salts, by adding a qualifier to…","rawSnapshotUrl":"/api/snapshots/raw/481708","browseUrl":"https://replay.healtharchive.ca/job-6/20260106172021/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/consultation-brimonidine.html?wbdisable=true#ha_snapshot=481708","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}